<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND AND OBJECTIVES: Endothelin-1 (ET-1), a potent vasoconstricting <z:chebi fb="7" ids="16670">peptide</z:chebi>, plays an important role in <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Previous in vitro studies have shown that <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells produce ET-1 </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: ET-1 and its receptors ET-A (ET(A) R) and ET-B (ET(B) R) were analyzed in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cell lines and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> by Western blot and immunohistochemistry </plain></SENT>
<SENT sid="3" pm="."><plain>Also, ET-1 levels were measured by ELISA in blood samples collected before and after <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> resection </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: ET-1 was immunohistochemically expressed by <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells at a variable level in 39 cases tested </plain></SENT>
<SENT sid="5" pm="."><plain>The adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa was negative for ET-1 expression </plain></SENT>
<SENT sid="6" pm="."><plain>Strong ET(A) R expression observed in the deeper infiltrating areas at the periphery of neoplastic tissue correlated significantly with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> stage </plain></SENT>
<SENT sid="7" pm="."><plain>ET(B) R levels were very low or undetectable </plain></SENT>
<SENT sid="8" pm="."><plain>Western blot analysis in paired (<z:mpath ids='MPATH_458'>normal</z:mpath>, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>) fresh-frozen samples of <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> and in four colon <z:mp ids='MP_0002038'>carcinoma</z:mp> cell lines confirmed these findings </plain></SENT>
<SENT sid="9" pm="."><plain>In addition, lower levels of ET-1 in the peripheral circulation after the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> resection were found by ELISA as compared to those observed before surgery </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: ET-1 and ET(A) R, but not ET(B) R, are expressed at a higher level in primary and cultured colon <z:mp ids='MP_0002038'>carcinoma</z:mp> cells as compared to <z:mpath ids='MPATH_458'>normal</z:mpath> colon mucosa cells </plain></SENT>
<SENT sid="11" pm="."><plain>Further functional studies are needed to explore the role of ET-1/ET(A) R axis in colon <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
</text></document>